Viatris Inc. · VTRS · Next earnings

Viatris Inc. reports Thursday, Nov 5, 2026

VTRS reports before market open with consensus EPS at $0.66 and revenue at $3.80B. Last quarter: Viatris Beats Q1 Estimates as Greater China Surges 18% and Pipeline Advances

Reports Before market open46 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $0.66 Calendar consensus
Consensus revenue $3.80B Calendar consensus
Report date Nov 5, 2026 Thursday, date estimated
Session Before market open 46 days away

Where VTRS left off: FY2026 Q1

Full report

Viatris Beats Q1 Estimates as Greater China Surges 18% and Pipeline Advances

EPS surprise +17.5% Reported $0.59 vs $0.50
Revenue surprise +4.8% Reported $3.52B vs $3.36B
Stock move +9.0% Event window
Subsequent drift -8.7% Up to 20 sessions

Management maintained full-year 2026 guidance, consistent with the prior quarter. The cost-savings program targeting $120M in 2026 remains on track. Capital allocation priorities -- dividends, share repurchases, and selective in-market acquisitions -- are unchanged, supported by $2.5B in cash.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Policy and reimbursement risk in Greater China could slow growth momentum
  • Supply constraints in lower-margin ARV and generic segments may pressure earnings
  • Regulatory uncertainty for pending approvals including XULANE LO, meloxicam, and pitolisant
  • Competitive pressure on generic products in developed markets
  • Margin pressure if cost-saving targets are not fully realized

Questions analysts left open

  • Durability of China growth and policy risk
  • Details on selatogrel primary endpoint and sample-size considerations
  • Drivers behind free cash flow changes year-over-year
  • Potential priority review and label specifics for fast-acting meloxicam
  • Composition of $71M new product revenue and channel inventory impact

Ask FN2 about VTRS next report

Transcript, numbers and history already loaded
What should I watch for in VTRS's next earnings report?How did VTRS guide last quarter, and is consensus above or below that?Give me the bull and bear case going into VTRS earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the VTRS recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent VTRS quarters

All VTRS earnings
+9.0%FY2026 Q1

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q1

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.